Sympathetic nerve activity and neurotransmitter release in humans: Translation from pathophysiology into clinical practice

Acta Physiologica Scandinavica

Volumn 177, Issue 3, 2003, Pages 275-284

  Esler, Murray ^a   Lambert, G ^a   Brunner La Rocca, H P ^a   Vaddadi, G ^a   Kaye, D ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Autonomic failure; Heart failure; Hypertension; Noradrenaline; Obesity

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 11; DOPAMINE BETA MONOOXYGENASE; DOPAMINE DERIVATIVE; EPHEDRINE DERIVATIVE; FLUORINE 18; FLUORODOPAMINE F 18; HYDROXYEPHEDRINE C 11; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; NORADRENALIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADRENERGIC RECEPTOR BLOCKING; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; HEART FAILURE; HUMAN; HYPERTENSION; MENTAL STRESS; NEUROGRAPHY; NEUROTRANSMITTER RELEASE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SHY DRAGER SYNDROME; SYMPATHETIC NERVE;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIAC OUTPUT, LOW; CATECHOLAMINES; DOPAMINE BETA-HYDROXYLASE; ELECTROPHYSIOLOGY; EPINEPHRINE; HUMANS; HYPERTENSION; MICROELECTRODES; NEURONS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; OBESITY; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM; SYNAPSES;

EID: 0037340342     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2003.01089.x     Document Type: Conference Paper

References (43)

1. Aggarwal, A., Esler, M.D., Lambert, G.W., Hastings, J., Johnston, L. & Kaye, D.M. 2002. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Circulation 105, 1031-1033.
2. Allman, K.C., Wieland, D.M., Muzik, O., Degrado, T.R., Wolfe, E.R. & Schwaiger, M. 1993. Carbon-11-hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 22, 368-375.
3. Brunner-La Rocca, H.P., Esler, M.D., Jennings, G.L. & Kaye, D.M. 2002. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 22, 1136-1143.
4. Cassis, L.A., Stitzel, R.E. & Head, R.J. 1985. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms. J Pharmacol Exp ther 234, 792-803.
5. Chidsey, C.A., Braunwald, E., Morrow, A.G. & Mason, D.T. 1963. Myocardial norepinephrine concentration in man: effects of reserpine and of congestive heart failure. N Engl J Med 269, 653-658.
6. Eisenhofer, G., Friberg, P., Rundqvist, B. et al. 1996. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93, 1667-1676.
7. Elam, M., Yao,T., Svensson, H. & Thoren, P. 1984. Regulation of locus coeruleus neurons and splanchnic sympathetic nerves by cardiovascular afferents. Brain Res 290, 281-287.
8. Esler, M., Julius, S., Zweifler, A. et al. 1977. Mild high-renin essential hypertension: a neurogenic human hypertension? N Engl J Med 296, 405-411.
9. Esler, M., Jennings, G., Korner, P., Blombery, P., Sacharias, N. & Leonard, P. 1984a. Measurement of total and organspecific norepinephrine kinetics in humans. Am J Physiol 247, E21-E28.
10. Esler, M., Jennings, G., Leonard, P. et al. 1984b. Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand Suppl 527, 11-16.
11. Esler, M., Jennings, G., Korner, P. et al. 1988. The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11, 3-20.
12. Esler, M., Wallin, G., Dorward, P. et al. 1991. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in man. Am J Physiol 260, R817-R823.
13. Esler, M. 2002. Differentiation of the effects of the angiotensin II receptor blocker class on autonomic function. J Hypertens 20 (suppl. 5):S13-19.
14. Ferrier, C., Jennings, G., Eisenhofer, G. et al. 1993. Evidence for increased noradrenaline release from subcortical brainregions in essential hypertension. J Hypertens 11, 1217-1227.
15. Goldstein, D.S., Chang, P.C., Eisenhofer, G., Miletich, R., Finn, R. & Bacher, J. 1990. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 81, 1606-1621.
16. Goldstein, D.S., Holmes, C., Cannon, R.O.III., Eisenhofer, G. & Kopin, I.J. 1997. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336, 696-702.
17. Grassi, G., Colombo, M., Seravalle, G., Spaziani, D. & Mancia, G. 1998. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31, 64-67.
18. Hagbarth, K.-E. & Vallbo, A.B. 1968. Pulse and respiratory grouping of sympathetic impulses in human muscle nerves. Acta Physiol Scand 74, 98-108.
19. Hasking, G., Esler, M., Jennings, G., Burton, D., Johns, J. & Korner, P. 1986. Norepinephrine spillover to plasma in congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73, 615-621.
20. CIBIS II Investigators and Committee. 1991. The cardiac insufficiency bisoprolol study II (CIBIS II). Lancet 353, 9-13.
21. Julius, S., Gundrandsson, T., Jamerson, K. & Andersson, O. 1992. The interconnection between sympathetics, micro-circulation and insulin resistance in hypertension. Blood Press 1, 9-19.
22. Kaye, D.M., Lambert, G.W., Lefkovits, J., Morris, M., Jennings, G.L. & Esler, M.D. 1994. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol, 23, 570-578.
23. Kaye, D.M., Lefkovits, J., Jennings, G.L., Bergin, P., Broughtom, A. & Esler, M.D. 1995. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26, 1257-1263.
24. Lambert, G.W., Ferrier, C., Kaye, D., Cox, H.S., Turner, A.G., Jennings, G.L. & Esler, M.D. 1994. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. Blood Press 3, 55-66.
25. Macefield, V., Wallin, B.G. & Vallbo, A.B. 1994. The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves. J Physiol (Lond) 481, 799-809.
26. Majewski, H, Rand, M.J. & Tung, I.H. 1981. Activation of prejunctional β-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter. Br J Pharmacol 73, 669-679.
27. Man In't Veld, A.J., Boomsma, F., Moleman, P. & Schalekamp, M.A.D.H. 1987. Congenital dopamine beta-hydroxylase deficiency: a novel orthostatic syndrome. Lancet 1, 183-187.
28. Meredith, I.T., Friberg, P., Jennings, G.L. et al. 1991a. Regular exercise lowers renal but not cardiac sympathetic activity in man. Hypertension 18, 575-582.
29. Meredith, I.T., Esler, M.D., Cox, H.S., Lambert, G.W., Jennings, G.L. & Eisenhofer, G. 1991b. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res 1, 187-194.
30. Messerli, F.H., Sundgaard-Riise, K., Reisin, E., Dreslinski, G., Dunn, F.G. & Frohlich, E. 1983. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 74, 808-812.
31. Packer, M., Bristow, M.R., Colucci, W.S., Fowler, M.B., Gilbert, E.M. & Shusterman, N.H. 1996. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334, 1349-1355.
32. Patel, K.P. & Zhang, K. 1996. Neurohumoral activation in heart failure. Clin Exp Pharmacol Physiol 23, 722-726.
33. Poulter, N.R., Khaw, K.T., Hopwood, B.E.C. et al. 1990. The Kenyan Luo migration study: observations on the initiation of the rise in blood pressure. Br Med J 300, 967-072.
34. Robertson, D.M., Goldberg, R., Onrot, J. et al. 1986. Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired β-hydroxylation of dopamine. N Engl J Med 314, 1494-1497.
35. Rumantir, M.S., Vaz, M., Jennings, G.L. et al. 1999. Neural mechanisms in human obesity-related hypertension. J Hypertens 17, 1125-1133.
36. Rumantir, M.S., Kaye, D.M., Jennings, G.L., Vaz, M., Hastings, J.A. & Esler, M.D. 2000a. Phenotypic evidence of faulty neuronal noradrenaline reuptake in essential hypertension. Hypertension 36, 824-829.
37. Rumantir, M.S., Jennings, G.L., Lambert, G.W., Kaye, D.M., Seals, D.R. & Esler, M.D. 2000b. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens 18, 717-723.
38. Specialist Medical Review Council. 2002. Statements of Principles Nos. 31 and 32 of 2001 Concerning Hypertension. Commonwealth of Australia Government Gazette. Australian Government Printer, Canberra, March 27.
39. Sundlof, G. & Wallin, B.G. 1977. The variability of muscle sympathetic nerve activity in resting recumbent man. J Physiol (Lond) 272, 383-397.
40. Thompson, J.M., O'Callaghan, C.J., Kingwell, B.A., Lambert, G.W., Jennings, G.L. & Esler, M.D. 1995. Total norepinephrine spillover, muscle sympathetic nerve activity and heart rate spectral analysis in a pateint with dopamine-beta-hydroxylase deficiency. J Auton Nerv Syst 55, 198-206.
41. Timio, M., Verdechioa, P., Rononi, M., Gentili, S., Francucci, B. & Bichisao, E. 1988. Age and blood pressure changes: a 20 year follow-up study of nuns of a secluded order. Hypertension 12, 457-461.
42. Waagstein, F., Bristow, M.R., Swedberg, K. et al. 1993. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342, 1441-1446.
43. Wilkinson, D.J.C., Thompson, J.M., Lambert, G.W. et al. 1998. Sympathetic activation in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry 55, 511-520.